Voliotis Dimitris
Insider CIK 1807910 · ZNTL SVP, Clinical Development · RADX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics Lt | A Award deriv | 2026-10-19 | 2026-10-27 | 10,295,666 | — | $0 | 10,295,666 | SEC↗ |
| RADX Radiopharm Theranostics Lt | A Award deriv | 2026-10-19 | 2026-10-27 | 10,295,667 | — | $0 | 10,295,667 | SEC↗ |
| RADX Radiopharm Theranostics Lt | A Award deriv | 2026-10-19 | 2026-10-27 | 10,295,667 | — | $0 | 10,295,667 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-14 | 2022-02-14 | 534 | $50.16 | $26.8K | 16,045 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-14 | 2022-02-14 | 67 | $50.75 | $3.4K | 15,978 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-02-10 | 2022-02-14 | 24,234 | — | $0 | 24,234 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2022-02-10 | 2022-02-14 | 10,329 | — | $0 | 16,579 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2022-01-20 | 2022-01-20 | 10,000 | — | $0 | 124,949 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2022-01-20 | 2022-01-20 | 10,000 | $18.00 | $180.0K | 16,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-20 | 2022-01-20 | 8,343 | $60.52 | $504.9K | 7,907 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-20 | 2022-01-20 | 1,657 | $61.21 | $101.4K | 6,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2022-01-19 | 2022-01-20 | 10,000 | — | $0 | 134,949 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2022-01-19 | 2022-01-20 | 10,000 | $18.00 | $180.0K | 16,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-19 | 2022-01-20 | 7,889 | $60.55 | $477.7K | 8,361 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-19 | 2022-01-20 | 1,556 | $61.51 | $95.7K | 6,805 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-19 | 2022-01-20 | 555 | $62.24 | $34.5K | 6,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2022-01-18 | 2022-01-20 | 10,000 | — | $0 | 144,949 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-20 | 1,997 | $63.48 | $126.8K | 7,550 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-20 | 3,294 | $62.34 | $205.3K | 9,547 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-20 | 3,409 | $61.70 | $210.3K | 12,841 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2022-01-18 | 2022-01-20 | 10,000 | $18.00 | $180.0K | 16,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-20 | 1,300 | $64.66 | $84.1K | 6,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2021-02-11 | 2021-02-16 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2021-02-11 | 2021-02-16 | 6,250 | — | $0 | 6,250 | SEC↗ |